Display options
Share it on

Indian Pacing Electrophysiol J. 2015 Apr 01;15(1):20-9. doi: 10.1016/S0972-6292(16)30838-5. eCollection 2015.

Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis.

Indian pacing and electrophysiology journal

Jayasree Pillarisetti, Martin Emert, Mazda Biria, Rashaad Chotia, Rajeshwer Guda, Sudharani Bommana, Rhea Pimentel, James Vacek, Dendi Raghuveer, Loren Berenbom, Buddhadeb Dawn, Dhanunjaya Lakkireddy

Affiliations

  1. Section of Electrophysiology, Division of Cardiovascular Medicine, KU Cardiovascular Research Institute, University of Kansas Hospital and Medical Center, Kansas City, KS 66193.

PMID: 25852239 PMCID: PMC4380691 DOI: 10.1016/S0972-6292(16)30838-5

Abstract

BACKGROUND: Despite ACC/AHA guidelines indicating implantable cardioverter defibrillator (ICD) as class I therapy for primary prevention of sudden cardiac death in patients with EF≤35%, ICD utilization rates in real world practice have been low.

OBJECTIVE: To determine the rate of ICD implantation at a tertiary care academic center and to assess the reasons for under-utilization of the same.

METHODS: Review of a prospectively collected database which included all patients diagnosed with an EF≤35% was performed to assess the rate of ICD implantation and mortality. Reasons for non-implantation of ICD were then assessed from detailed chart review.

RESULTS: A total of 707 patients (age 69.4 ± 14.1 years) with mean EF of 26±7% were analyzed. Only 28% (200/707) of patients had ICDs implanted. Mortality was lower in the group with ICD (25% vs 37%, p=0.004). When patients who either died or were lost to follow-up prior to 2005 were excluded, ICD utilization rate was still low at 37.6%. The most common reason for non-implantation of ICD was physicians not discussing this option with their patients. Patient refusal was the second most common reason.

CONCLUSIONS: ICD Implantation rates for primary prevention of SCD in patients with EF≤35% is low. Physician and patient education should be addressed to improve the utilization rates.

Keywords: Implantable cardioverter-defibrillator; Outcomes; sudden cardiac death

References

  1. Circulation. 2009 Apr 14;119(14):1977-2016 - PubMed
  2. Circulation. 1995 Feb 1;91(3):691-7 - PubMed
  3. JAMA. 2007 Oct 3;298(13):1517-24 - PubMed
  4. N Engl J Med. 2002 Mar 21;346(12):877-83 - PubMed
  5. N Engl J Med. 2005 Jan 20;352(3):225-37 - PubMed
  6. Pacing Clin Electrophysiol. 2010 Jun 1;33(6):727-33 - PubMed
  7. N Engl J Med. 1996 Dec 26;335(26):1933-40 - PubMed
  8. Am Heart J. 2009 Apr;157(4):754-62.e2 - PubMed
  9. N Engl J Med. 1992 Sep 3;327(10):669-77 - PubMed
  10. J Am Geriatr Soc. 1998 Dec;46(12):1550-4 - PubMed
  11. N Engl J Med. 1999 Dec 16;341(25):1882-90 - PubMed
  12. Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):146-51 - PubMed
  13. N Engl J Med. 1999 Sep 2;341(10):709-17 - PubMed
  14. Lancet. 1999 Jun 12;353(9169):2001-7 - PubMed
  15. N Engl J Med. 2005 Oct 6;353(14):1471-80 - PubMed
  16. Am J Cardiol. 2007 Sep 15;100(6):924-9 - PubMed
  17. N Engl J Med. 2002 Oct 31;347(18):1397-402 - PubMed
  18. J Am Coll Cardiol. 2009 Feb 3;53(5):416-22 - PubMed
  19. JAMA. 2007 Oct 3;298(13):1525-32 - PubMed
  20. Circulation. 2005 Sep 20;112(12):e154-235 - PubMed
  21. J Gen Intern Med. 1997 Sep;12(9):563-6 - PubMed

Publication Types